Published in Childs Nerv Syst on December 19, 2009
Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. Radiat Oncol (2012) 1.08
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol (2014) 0.84
New strategies in radiation therapy: exploiting the full potential of protons. Clin Cancer Res (2013) 0.78
Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med (1993) 4.28
Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys (2002) 3.21
Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med (1993) 2.53
Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol (2004) 1.83
The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys (1995) 1.75
Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 1.60
The clinical potential of intensity modulated proton therapy. Z Med Phys (2004) 1.59
Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys (1990) 1.53
Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys (2008) 1.32
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol (1997) 1.24
Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys (2005) 1.24
A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol (1999) 1.24
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer (2007) 1.21
Treatment planning for conformal proton radiation therapy. Technol Cancer Res Treat (2003) 1.19
A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys (2004) 1.18
Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol (2005) 1.15
Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg (2002) 1.14
Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys (1994) 1.07
Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys (2000) 1.06
Current management of childhood ependymoma. Oncology (Williston Park) (2002) 0.99
Inverse planning for photon and proton beams. Med Dosim (2001) 0.95
Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediatr Oncol (1996) 0.94
Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol (2002) 0.93
Optimization of beam parameters and treatment planning for intensity modulated proton therapy. Technol Cancer Res Treat (2003) 0.93
The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv Syst (2000) 0.92
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer (1997) 0.92
Intensity modulated radiotherapy with charged particle beams: studies of inverse treatment planning for rotation therapy. Med Phys (2000) 0.90
Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg (1997) 0.90
Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg (1996) 0.89
Short- and long-term complications of radiation therapy for pediatric brain tumors. Pediatr Neurosurg (1992) 0.87
Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg (1998) 0.86
Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg (1998) 0.85
Pediatric sensorineural hearing loss after temporal bone radiation. Am J Otol (1995) 0.84
Intracranial ependymomas of childhood: current management strategies. Pediatr Neurosurg (2000) 0.83
Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg (1983) 0.80
Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. Int J Radiat Oncol Biol Phys (2007) 0.79
The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? Int J Radiat Oncol Biol Phys (2001) 0.78
Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas? Cancer (1991) 0.77
Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys (2013) 1.89
Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol (2012) 1.70
Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer (2005) 1.54
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys (2008) 1.34
An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol (2012) 1.28
Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects. Int J Radiat Oncol Biol Phys (2011) 1.24
Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation. Int J Radiat Oncol Biol Phys (2007) 1.23
Platelet-derived growth factor receptor-beta in Gorham's disease. Nat Clin Pract Oncol (2006) 1.23
Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.12
Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer (2013) 1.10
Radiation therapy for pediatric central nervous system tumors. J Child Neurol (2009) 1.09
Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys (2010) 1.05
Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.03
Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer (2008) 1.02
Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer (2011) 1.01
Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol (2013) 1.00
Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys (2008) 1.00
Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys (2013) 1.00
In vivo proton beam range verification using spine MRI changes. Int J Radiat Oncol Biol Phys (2010) 1.00
Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys (2013) 0.93
Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys (2011) 0.92
Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison. Int J Radiat Oncol Biol Phys (2011) 0.92
Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Phys Med Biol (2012) 0.92
Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. Int J Radiat Oncol Biol Phys (2007) 0.92
Novel molecular pathways in Gorham disease: implications for treatment. Pediatr Blood Cancer (2013) 0.91
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab (2007) 0.91
Changes in cerebral cortex of children treated for medulloblastoma. Int J Radiat Oncol Biol Phys (2007) 0.91
The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors. Phys Med Biol (2014) 0.87
Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications. Neuro Oncol (2013) 0.86
Proton radiotherapy for solid tumors of childhood. Technol Cancer Res Treat (2012) 0.85
Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr (2013) 0.84
Role of radiation therapy in pediatric cancer. Hematol Oncol Clin North Am (2006) 0.83
The family impacts of proton radiation therapy for children with brain tumors. J Pediatr Oncol Nurs (2012) 0.83
Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol (2013) 0.81
Case records of the Massachusetts General Hospital. Case 20-2007. An 11-year-old boy with a calcified mass in the nose. N Engl J Med (2007) 0.80
The development of Moyamoya syndrome after proton beam therapy. Pediatr Blood Cancer (2014) 0.78
Elevation of prostaglandin E2 in lung cancer patients with digital clubbing. J Thorac Oncol (2012) 0.76
Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer (2015) 0.75